238 related articles for article (PubMed ID: 34858987)
1. Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2021; 9():765772. PubMed ID: 34858987
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2022; 10():1009752. PubMed ID: 36225317
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.
Jiang X; Yuan Y; Tang L; Wang J; Liu Q; Zou X; Duan L
Front Cell Dev Biol; 2024; 12():1392532. PubMed ID: 38645409
[TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p.
Wei L; Yang N; Sun L; Zhang L; Li Z; Li D; Qin T; Huang H
Transl Cancer Res; 2019 Sep; 8(5):2141-2150. PubMed ID: 35116964
[TBL] [Abstract][Full Text] [Related]
8. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.
Xu Y; Bao Y; Qiu G; Ye H; He M; Wei X
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772373
[TBL] [Abstract][Full Text] [Related]
9. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
Qi L; Yin Y; Sun M
Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p.
Lu Q; Shan S; Li Y; Zhu D; Jin W; Ren T
FASEB J; 2018 Jul; 32(7):3957-3967. PubMed ID: 29466052
[TBL] [Abstract][Full Text] [Related]
11. SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.
Li J; Zhang Z; Xiong L; Guo C; Jiang T; Zeng L; Li G; Wang J
Biochem Biophys Res Commun; 2017 May; 487(1):146-152. PubMed ID: 28400279
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
Xu J; Xu Y; Ye G; Qiu J
J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
[TBL] [Abstract][Full Text] [Related]
13. FOXM1/lncRNA TYMSOS/miR-214-3p-Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Carcinoma.
Yuan Y; Jiang X; Tang L; Wang J; Zhang D; Cho WC; Duan L
Front Mol Biosci; 2021; 8():785767. PubMed ID: 35211508
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
Zhang N; Liu FL; Ma TS; Zhang ZZJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
[TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of MicroRNA-21 Indicates Poor Prognosis and Promotes Cell Proliferation in Esophageal Squamous Cell Carcinoma via Upregulation of lncRNA SNHG1.
Luo D; Huang Z; Lv H; Wang Y; Sun W; Sun X
Cancer Manag Res; 2020; 12():1-14. PubMed ID: 32021418
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
18. m
Wu X; Fu M; Ge C; Zhou H; Huang H; Zhong M; Zhang M; Xu H; Zhu G; Hua W; Lv K; Yang H
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38193984
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer.
Kang Y; Wan L; Wang Q; Yin Y; Liu J; Liu L; Wu H; Zhang L; Zhang X; Xu S; Pang D
Cell Biosci; 2021 Aug; 11(1):169. PubMed ID: 34465388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
